Re "Lawmakers send Brown bill on biosimilar medication" (Sacbee.com, Sept. 4): The Biotechnology Industry Organization (BIO) applauds the California Legislature for taking measures to ensure physicians and patients remain in control of their treatment choices.
SB 598 ultimately will impact severely ill patients who rely on cutting-edge medical treatments. Biosimilars are safe and effective. BIO applauds the California Legislator for taking a national leadership role in developing this legislation and encourages Gov. Jerry Brown to sign this bill into law.
-- Fritz Bittenbender, Washington, DC